Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|August 24, 2019
Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumoursBárbara Dos Santos Passaia, Keli Lima, Jean Lucas Kremer, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 3, 2025
Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemiaGustavo Nery de Queiroz, Keli Lima, Marcella Cipelli, et al.
Cancer Science|November 22, 2021
Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasmsHisashi Takei, Juan Luiz Coelho-Silva, Cristina Tavares Leal, et al.
European Journal of Pharmacology|January 10, 2021
Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cellsHugo Passos Vicari, Keli Lima, Ralph da Costa Gomes, et al.
Cells|February 15, 2022
Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP-FRB Interaction and AutophagyCarolina A Parada, Ivan Pires de Oliveira, Mayara C F Gewehr, et al.
European Journal of Pharmacology|November 30, 2024
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cellsJean Carlos Lipreri da Silva, Keli Lima, Benjamin Ede, et al.
Journal of Natural Products|December 4, 2025
Cephalochromin Effects in Triple-Negative Breast Cancer Cells: Apoptosis Induction and Modulation of Survival PathwaysIsabelle Diccini, Natália Sudan Parducci, Bruna Oliveira de Almeida, et al.
European Journal of Pharmacology|April 17, 2026
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escapeLivia Bassani Lins de Miranda, Keli Lima, Diego A Pereira-Martins, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 20, 2026
Dual inhibition of MMP-2 and actin dynamics by a novel bis-chalcone: an anticancer strategy for oral squamous cell carcinomaRodrigo Elísio de Sá, Bruna Oliveira de Almeida, Marcelo da Costa Mota, et al.
European Journal of Pharmacology|June 8, 2024
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemiaKeli Lima, Frederico Lisboa Nogueira, Marcella Cipelli, et al.
Pageof 5